Search

Your search keyword '"Bliddal, H."' showing total 1,362 results

Search Constraints

Start Over You searched for: Author "Bliddal, H." Remove constraint Author: "Bliddal, H."
1,362 results on '"Bliddal, H."'

Search Results

59. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial

60. Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6 Months Prospective Study

62. Improved nutritional status and bone health after diet-induced weight loss in sedentary osteoarthritis patients: a prospective cohort study

66. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.

69. Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study

71. EFFECT OF WEIGHT LOSS AND LIRAGLUTIDE ON SERUM URATE LEVELS AMONG OBESE KNEE OSTEOARTHRITIS PATIENTS:SECONDARY ANALYSIS OF A RANDOMISED CONTROLLED TRIAL

72. Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches:a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis

73. The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis:a prospective cohort study

74. The effects of weight loss on imaging outcomes in osteoarthritis of the hip or knee in people who are overweight or obese:a systematic review

85. OP0172 EFFECT OF WEIGHT LOSS AND LIRAGLUTIDE ON SERUM URATE LEVELS AMONG OBESE KNEE OSTEOARTHRITIS PATIENTS: SECONDARY ANALYSIS OF A RANDOMISED CONTROLLED TRIAL

86. FRI0019 MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL

87. AB0209 PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY

97. A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

98. The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity

Catalog

Books, media, physical & digital resources